GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 38 filers reported holding GALERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,898 | -94.5% | 370,643 | -1.1% | 0.00% | – |
| Q2 2023 | $1,169,341 | +43.0% | 374,789 | +17.3% | 0.00% | – |
| Q1 2023 | $817,971 | +84.6% | 319,520 | +7.5% | 0.00% | – |
| Q4 2022 | $443,010 | -18.4% | 297,323 | -4.8% | 0.00% | – |
| Q3 2022 | $543,000 | +32.4% | 312,230 | -0.8% | 0.00% | – |
| Q2 2022 | $410,000 | -46.4% | 314,659 | -2.1% | 0.00% | – |
| Q1 2022 | $765,000 | -3.2% | 321,292 | +86.8% | 0.00% | – |
| Q4 2021 | $790,000 | -47.5% | 172,039 | -7.5% | 0.00% | – |
| Q3 2021 | $1,505,000 | -17.4% | 185,910 | +0.4% | 0.00% | – |
| Q2 2021 | $1,821,000 | -65.1% | 185,141 | -68.7% | 0.00% | – |
| Q1 2021 | $5,218,000 | -5.0% | 591,727 | +10.2% | 0.00% | – |
| Q4 2020 | $5,493,000 | +43.7% | 536,965 | +27.1% | 0.00% | – |
| Q3 2020 | $3,822,000 | +34.8% | 422,640 | +6.4% | 0.00% | – |
| Q2 2020 | $2,836,000 | +317.1% | 397,177 | +455.0% | 0.00% | – |
| Q1 2020 | $680,000 | -23.6% | 71,557 | +5.8% | 0.00% | – |
| Q4 2019 | $890,000 | – | 67,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 613,223 | $2,815,000 | 0.83% |
| Sofinnova Investments, Inc. | 3,083,712 | $14,154,000 | 0.83% |
| Novo Holdings A/S | 2,459,021 | $11,287,000 | 0.53% |
| ACUTA CAPITAL PARTNERS, LLC | 262,500 | $1,205,000 | 0.51% |
| Tekla Capital Management LLC | 898,374 | $4,124,000 | 0.13% |
| Aristides Capital LLC | 20,000 | $92,000 | 0.04% |
| XTX Topco Ltd | 13,499 | $62,000 | 0.04% |
| Blackstone Inc. | 1,678,984 | $7,707,000 | 0.02% |
| Taylor Wealth Management Partners | 11,635 | $53,000 | 0.02% |
| Belvedere Trading LLC | 96,486 | $255,000 | 0.01% |